Selector High Conviction Equity Fund

December 2021 Quarterly Newsletter

In this quarterly edition we review SFML performance, attribution and ESG. We explore the qualitative factors behind a great business in our article “Firms of Endearment”. Looking at future trends, we delve into the ongoing structural shift towards personalised healthcare and profile an Australian health insurer leading this space. Some are calling the next era for business operators as the “efficiency decade” and we explore one of its pivotal technologies, Artificial Intelligence (AI) through the lens of Appen. Our discussion on proxy advisors returns in our piece “Proxy advisors under the spotlight”. We finish with ESG by reviewing high level disinfection company, Nanosonics, as well as the potential impact of a Carbon Tax on the portfolio.

This update has been prepared by Selector Funds Management Limited (“Selector”) ACN 102 856 347 AFSL 225316 to provide you with general information only. In preparing this update, we do not take into account your investment objectives, financial situation or particular needs. It is not intended to take the place of professional advice and you should not take action in reliance on this information. Neither Selector, or any of its related parties, their employees or directors, provide a warranty of accuracy or reliability for this information or accept any liability to any person who relies on it. Past performance is not an indicator of future performance. Selector does not guarantee the repayment of capital, payment of income or performance. Unauthorised use, copying, distribution, transmitting, publication, display, or reproduction in whole or in part of the information contained in this material is prohibited without prior written consent from Selector.

Unauthorised use, copying, distribution, transmitting, publication, display, or reproduction in whole or in part of the information contained in this material is prohibited without prior written consent from Selector.